Adagene
Patents, Design & Utilities

Last updated:

List of all Adagene patents 13 in total

Status Patent
Application
Utility: ANTI-CD137 MOLECULES AND USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2022
Grant
Utility: Anti-CTLA4 antibodies and methods of making and using the same External link
Filling date: 6 Sep 2025 Issue date: 14 Jun 2022
Application
Utility: INTEGRATED SYSTEM FOR LIBRARY CONSTRUCTION, AFFINITY BINDER SCREENING AND EXPRESSION THEREOF External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2022
Grant
Utility: Anti-CD137 molecules and use thereof External link
Filling date: 6 Sep 2025 Issue date: 8 Feb 2022
Application
Utility: ACTIVATABLE ANTIBODIES AND METHODS OF MAKING AND USING THEREOF External link
Filling date: 6 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: ANTI-CTLA4 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME External link
Filling date: 6 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: ANTI-PD-L1 ANTIBODIES AND USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: METHODS FOR USING CD137 LIGAND AS A BIOMARKER FOR TREATMENT WITH ANTI-CD137 ANTIBODY External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: ANTI-CD137 MOLECULES AND USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 26 Nov 2020
Application
Utility: DYNAMIC HUMAN ANTIBODY LIGHT CHAIN LIBRARIES External link
Filling date: 6 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: DYNAMIC HUMAN HEAVY CHAIN ANTIBODY LIBRARIES External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: PRECISION/CONTEXT-DEPENDENT ACTIVATABLE ANTIBODIES, AND METHODS OF MAKING AND USING THE SAME External link
Filling date: 6 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: ANTI-CTLA4 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME External link
Filling date: 6 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 13 of 13 patents.